A detailed history of Steward Partners Investment Advisory, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 381,288 shares of PFE stock, worth $10.1 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
381,288
Previous 371,637 2.6%
Holding current value
$10.1 Million
Previous $10.4 Million 6.12%
% of portfolio
0.1%
Previous 0.11%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$27.7 - $31.39 $267,332 - $302,944
9,651 Added 2.6%
381,288 $11 Million
Q2 2024

Aug 08, 2024

SELL
$25.26 - $29.6 $248,735 - $291,471
-9,847 Reduced 2.58%
371,637 $10.4 Million
Q1 2024

May 15, 2024

BUY
$25.89 - $29.73 $849,683 - $975,708
32,819 Added 9.41%
381,484 $10.6 Million
Q4 2023

Feb 12, 2024

SELL
$26.13 - $33.94 $3.64 Million - $4.72 Million
-139,114 Reduced 28.52%
348,665 $10 Million
Q3 2023

Nov 13, 2023

BUY
$32.09 - $37.51 $248,280 - $290,214
7,737 Added 1.61%
487,779 $16.2 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $40,887 - $47,306
1,132 Added 0.24%
480,042 $17.6 Million
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $474,098 - $617,206
12,036 Added 2.58%
478,910 $19.5 Million
Q4 2022

Feb 15, 2023

SELL
$41.75 - $54.5 $1.08 Million - $1.41 Million
-25,867 Reduced 5.25%
466,874 $23.9 Million
Q3 2022

Nov 10, 2022

BUY
$43.76 - $53.42 $24,461 - $29,861
559 Added 0.11%
492,741 $21.6 Million
Q2 2022

Aug 04, 2022

SELL
$46.53 - $55.17 $13,214 - $15,668
-284 Reduced 0.06%
492,182 $25.8 Million
Q1 2022

May 02, 2022

BUY
$45.75 - $56.69 $224,403 - $278,064
4,905 Added 1.01%
492,466 $25.5 Million
Q4 2021

Feb 08, 2022

BUY
$41.32 - $61.25 $265,150 - $393,041
6,417 Added 1.33%
487,561 $28.8 Million
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $704,341 - $904,786
17,945 Added 3.87%
481,144 $20.7 Million
Q2 2021

Aug 13, 2021

SELL
$35.91 - $40.68 $2.33 Million - $2.64 Million
-64,827 Reduced 12.28%
463,199 $18.1 Million
Q1 2021

May 14, 2021

BUY
$33.49 - $37.77 $2.48 Million - $2.8 Million
74,118 Added 16.33%
528,026 $19.1 Million
Q4 2020

Feb 11, 2021

BUY
$33.47 - $42.56 $1.19 Million - $1.51 Million
35,516 Added 8.49%
453,908 $16.7 Million
Q3 2020

Oct 30, 2020

BUY
$31.75 - $37.25 $2.01 Million - $2.35 Million
63,165 Added 17.78%
418,392 $15.4 Million
Q2 2020

Aug 06, 2020

SELL
$30.12 - $36.54 $1.28 Million - $1.56 Million
-42,632 Reduced 10.72%
355,227 $11.6 Million
Q1 2020

Apr 29, 2020

BUY
$27.03 - $38.62 $711,159 - $1.02 Million
26,310 Added 7.08%
397,859 $13 Million
Q4 2019

Jan 17, 2020

SELL
$32.92 - $37.36 $143,300 - $162,628
-4,353 Reduced 1.16%
371,549 $14.6 Million
Q3 2019

Oct 30, 2019

SELL
$32.49 - $42.13 $274,215 - $355,577
-8,440 Reduced 2.2%
375,902 $13.5 Million
Q2 2019

Jul 25, 2019

BUY
$36.98 - $41.52 $740,339 - $831,230
20,020 Added 5.5%
384,342 $16.6 Million
Q1 2019

Apr 30, 2019

BUY
$37.5 - $41.2 $103,012 - $113,176
2,747 Added 0.76%
364,322 $15.5 Million
Q4 2018

Jan 15, 2019

BUY
$38.47 - $43.86 $822,988 - $938,296
21,393 Added 6.29%
361,575 $15.8 Million
Q3 2018

Oct 23, 2018

BUY
$34.47 - $41.81 $1.89 Million - $2.29 Million
54,857 Added 19.23%
340,182 $15 Million
Q2 2018

Jul 20, 2018

BUY
$32.98 - $35.16 $1.89 Million - $2.01 Million
57,176 Added 25.06%
285,325 $10.4 Million
Q1 2018

Apr 20, 2018

BUY
$31.91 - $37.02 $47,609 - $55,233
1,492 Added 0.66%
228,149 $8.1 Million
Q4 2017

Jan 19, 2018

BUY
$33.26 - $35.29 $864,061 - $916,798
25,979 Added 12.95%
226,657 $8.21 Million
Q3 2017

Nov 22, 2017

BUY
$31.0 - $34.15 $276,954 - $305,096
8,934 Added 4.66%
200,678 $7.16 Million
Q2 2017

Nov 22, 2017

BUY
N/A
28,874 Added 17.73%
191,744 $6.44 Million
Q1 2017

Nov 22, 2017

BUY
N/A
107,635 Added 194.87%
162,870 $5.57 Million
Q4 2016

Nov 22, 2017

BUY
N/A
55,235
55,235 $1.79 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Steward Partners Investment Advisory, LLC Portfolio

Follow Steward Partners Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.